Hyperuricemia is independently associated with endothelial dysfunction in postmenopausal women but not in

Tatsuya Maruhashi1, Ayumu Nakashima, Junko Soga

  • 1Department of Cardiovascular Medicine, Hiroshima University Graduate School of Biomedical Sciences, Hiroshima, Japan.

BMJ Open
|November 12, 2013
PubMed

Insights

High uric acid levels are linked to endothelial dysfunction in women, especially postmenopausal individuals. This suggests uric acid can serve as a valuable risk marker for cardiovascular health.

Area of Science:

  • Cardiovascular Health
  • Endocrinology
  • Vascular Biology

Background:

  • Endothelial dysfunction is a key factor in cardiovascular disease development.
  • Uric acid's role in cardiovascular risk is debated, particularly concerning its relationship with endothelial function.
  • Menopausal status may influence the association between uric acid and vascular health in women.

Purpose of the Study:

  • To examine the relationship between serum uric acid levels and endothelial function in Japanese women.
  • To identify cardiovascular risk factors associated with uric acid levels.
  • To investigate if menopausal status modifies the link between uric acid and endothelial function.

Main Methods:

  • Cross-sectional study involving 749 Japanese women aged 30-74 years.
  • Serum uric acid levels and flow-mediated vasodilation (FMD) were measured.
  • Endothelial dysfunction was defined as FMD ≤4.90%; menopausal status was categorized.

Main Results:

  • Serum uric acid levels correlated significantly with age, BMI, blood pressure, lipids, glucose, eGFR, and Framingham risk score.
  • Flow-mediated vasodilation (FMD) decreased progressively with increasing uric acid levels (p=0.01).
  • Uric acid was an independent risk factor for endothelial dysfunction in postmenopausal women (OR 1.23) but not in premenopausal women.

Conclusions:

  • Serum uric acid is a potential risk marker for endothelial dysfunction in women.
  • Uric acid is an independent risk factor for endothelial dysfunction specifically in postmenopausal women.
  • These findings highlight the importance of considering menopausal status when evaluating uric acid's cardiovascular risk.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.8K
Microbiota of the Urogenital Tract01:28

Microbiota of the Urogenital Tract

The human urogenital system, once thought to be sterile in healthy individuals, is now recognized as a complex microbial habitat. Advancements in molecular sequencing techniques have revealed that even in healthy adults, the kidneys and bladder harbor microbial populations similar to those found in the distal urethra, albeit in much lower abundance. These resident microorganisms, while generally innocuous, can become opportunistic pathogens under conditions that alter the urogenital...
59
Urinary Tract Calculi IV: Nutrition Therapy and Prevention01:27

Urinary Tract Calculi IV: Nutrition Therapy and Prevention

Management of renal calculi focuses on effective strategies like tailored nutrition and hydration therapy. Adjusting diet and fluid intake reduces stone formation and recurrence, making these interventions simple yet powerful in kidney stone prevention and management.Understanding Kidney StonesKidney stones form when calcium, oxalate, uric acid, and cystine concentrate and crystallize in urine. Factors contributing to their formation include genetic predisposition, certain medical conditions,...
764
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
769
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
405
Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations01:26

Urinary Tract Calculi II: Pathophysiology and Clinical Manifestations

Renal calculi, commonly termed kidney stones, are crystalline solid masses that form in the kidneys but can occur at any point within the urinary system, encompassing the kidneys, ureters, bladder, and urethra.The pathophysiology of renal stones involves several key factors: supersaturation of the urine with stone-forming constituents, changes in urine pH, a decrease in urine volume, and the presence of substances that promote or inhibit stone formation.Supersaturation of Urine: This is the...
863